Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹70 Cr
P/E Ratio
82.82
P/B Ratio
6.09
Industry P/E
295.12
Debt to Equity
0.11
ROE
-23.34 %
ROCE
-18.49 %
Div. Yield
0 %
Book Value
11.17
EPS
0.82
CFO
₹-2.97 Cr
EBITDA
₹-1.65 Cr
Net Profit
₹-14.60 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Aspira Pathlab
| 10.92 | -26.43 | -15.11 | 108.86 | 7.22 | -- | -- |
|
BSE Healthcare
| -5.78 | 2.62 | 3.66 | 20.07 | 20.57 | 22.14 | 10.31 |
|
BSE Small Cap
| -12.04 | 2.97 | -0.32 | 2.02 | 18.80 | 34.92 | 16.25 |
|
2024
|
2023
|
2022
|
2021
|
|
|---|---|---|---|---|
|
Aspira Pathlab
| 52.56 | -8.99 | -44.20 | 180.58 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 | 20.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 79.04 | 166.81 | 325.16 | 0.84 | |
| 160.05 | 53.71 | 4.43 | 31.12 | |
| 19.85 | 29.40 | -- | -2.13 | |
| 66.97 | 28.67 | -- | -100.92 |
No Review & Analysis are available.
Hospital activities
Incorporated
1973
Chairman
Haseeb Drabu
Managing Director
Pankaj Shah
Headquarters
Mumbai, Maharashtra
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The total asset value of Aspira Pathlab & Diagnostics Ltd stood at ₹ 16 Cr as on 31-Dec-24
The share price of Aspira Pathlab & Diagnostics Ltd is ₹66.00 (BSE) as of 28-Apr-2025 16:01 IST. Aspira Pathlab & Diagnostics Ltd has given a return of 7.22% in the last 3 years.
Aspira Pathlab & Diagnostics Ltd has a market capitalisation of ₹ 70 Cr as on 28-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Aspira Pathlab & Diagnostics Ltd is 6.09 times as on 28-Apr-2025, a 141% premium to its peers’ median range of 2.53 times.
The P/E ratio of Aspira Pathlab & Diagnostics Ltd is 82.82 times as on 28-Apr-2025, a 72% discount to its peers’ median range of 295.12 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Aspira Pathlab & Diagnostics Ltd and enter the required number of quantities and click on buy to purchase the shares of Aspira Pathlab & Diagnostics Ltd.
Hospital activities
The promoters of Aspira Pathlab & Diagnostics Ltd are ARVIND KARSANDAS BHANUSHALI and DEEPALI ARVIND BHANUSHALI. They collectively own 17.2 per cent of the total equity. The chairman of the company is Haseeb Drabu
There is no promoter pledging in Aspira Pathlab & Diagnostics Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
151
|
|
|
52
|
|
|
28
|
|
|
27
|
| Aspira Pathlab & Diagnostics Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
7.95
|
|
Operating margin(%)
|
4.25
|
|
Net Margin(%)
|
4.15
|
|
Dividend yield(%)
|
0
|
Yes, TTM profit after tax of Aspira Pathlab & Diagnostics Ltd was ₹1 Cr.
₹-1.99
(
